Sirona Biochem Corp. (SRBCF)

Sirona Biochem Income Statement

Financials in millions CAD. Fiscal year is November - October.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jul 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020	Oct 31, 2019
Operating Revenue	-0.02	0.03	0.67	0.27	0.11	0.14
Revenue	-0.02	0.03	0.67	0.27	0.11	0.14
Revenue Growth (YoY)	-	-94.82%	150.70%	153.54%	-22.12%	-89.38%
Cost of Revenue	0.07	0.06	0.05	0.07	0.05	-
Gross Profit	-0.08	-0.03	0.62	0.2	0.05	0.14
Selling, General & Admin	1.08	1.25	1.65	1.06	1.16	2.01
Research & Development	0.9	0.99	0.89	0.93	1.25	1.26
Operating Expenses	2.18	2.28	4.01	2.33	4.05	4.33
Operating Income	-2.27	-2.31	-3.39	-2.13	-4	-4.2
Interest Expense	-0.4	-0.2	-0.03	-0	-0.01	-0.12
Interest & Investment Income	-	-	-	-	-	0.03
Currency Exchange Gain (Loss)	-0	-0	0.01	-0.02	0	0
Other Non Operating Income (Expenses)	0.01	-0.03	-0.14	-0.15	-0.13	-0.27
EBT Excluding Unusual Items	-2.66	-2.54	-3.55	-2.31	-4.14	-4.56
Pretax Income	-2.66	-2.54	-3.55	-2.31	-4.14	-4.56
Income Tax Expense	0	-0	0.01	-0.01	-0.01	-0.01
Net Income	-2.67	-2.54	-3.56	-2.31	-4.13	-4.55
Net Income to Common	-2.67	-2.54	-3.56	-2.31	-4.13	-4.55
Shares Outstanding (Basic)	255	252	241	229	226	201
Shares Outstanding (Diluted)	255	252	241	229	226	201
Shares Change (YoY)	2.79%	4.59%	5.16%	1.41%	12.32%	17.15%
EPS (Basic)	-0.01	-0.01	-0.01	-0.01	-0.02	-0.02
EPS (Diluted)	-0.01	-0.01	-0.01	-0.01	-0.02	-0.02
Free Cash Flow	-2.03	-1.76	-2.18	-2.16	-2.16	-3.56
Free Cash Flow Per Share	-0.01	-0.01	-0.01	-0.01	-0.01	-0.02
Gross Margin	-	-82.71%	92.53%	74.34%	48.79%	100.00%
Operating Margin	-	-6649.66%	-504.45%	-796.37%	-3779.24%	-3093.19%
Profit Margin	-	-7312.43%	-529.50%	-860.50%	-3910.40%	-3351.61%
Free Cash Flow Margin	-	-5053.37%	-324.07%	-805.24%	-2042.43%	-2622.23%
EBITDA	-2.26	-2.3	-3.38	-2.12	-3.99	-
D&A For EBITDA	0.01	0.01	0.01	0.01	0.01	-
EBIT	-2.27	-2.31	-3.39	-2.13	-4	-4.2

Source: S&P Global Market Intelligence. Standard template. Financial Sources.